ACCD (Accolade) Total Current Assets : $274.7 Mil (As of Aug. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Accolade Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Accolade's total current assets for the quarter that ended in Aug. 2024 was $274.7 Mil.

Accolade Total Current Assets Historical Data

The historical data trend for Accolade's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accolade Total Current Assets Chart

Accolade Annual Data

Trend

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Total Current Assets

Get a 7-Day Free Trial

48.94

453.98

409.14

365.95

284.91

Accolade Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Total Current Assets	Get a 7-Day Free Trial															336.26	272.09	284.91	275.26	274.74

Accolade Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Accolade's Total Current Assets for the fiscal year that ended in Feb. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	237.033	+	27.702	+	0	+	20.177
	=	284.9

Accolade's Total Current Assets for the quarter that ended in Aug. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	234.35	+	25.218	+	0	+	15.168
	=	274.7

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Accolade (NAS:ACCD) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Accolade's Liquidation Value for the quarter that ended in Aug. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	234.35	-	332.998	+	0.75 * 21.224	+	0.5 * 0
=	-82.7

Accolade Total Current Assets Related Terms

Thank you for viewing the detailed overview of Accolade's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Accolade Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Accolade Inc (NAS:ACCD) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

4NE1:Germany

Address

1201 Third Avenue, Suite 1700, Seattle, WA, USA, 98101

Website

https://www.accolade.com

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Executives

Mchugh Colin	officer: Chief Accounting Officer	C/O ACCOLADE, INC., 660 W. GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Richard Eskew	officer: EVP General Counsel	C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Stephen H. Barnes	officer: Chief Financial Officer	C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Rajeev Singh	director, officer: Chief Executive Officer	6222 185TH AVENUE NE, REDMOND WA 98052
Robert N Cavanaugh	officer: President	1601 CLOVERFIELD BLVD., SUITE 620, SANTA MONICA CA 90404
Michael W Hilton	officer: Chief Product Officer	6222 185TH AVE, REDMOND WA 98052
Peter S Klein	director	C/O MICROSOFT CORPORATION, ONE MICROSOFT WAY, REDMOND WA 98052-6399
Cindy Kent	director	7601 PENN AVENUE SOUTH, RICHFIELD MN 55418
Patricia L Wadors	director	C/O ALIGN TECHNOLOGY INC, 881 MARTIN AVE, SANTA CLARA CA 95050
Dawn G Lepore	director	1425 BROADWAY PMB 41, SEATTLE WA 99122
Jeffrey D Jordan	director	2865 SAND HILL ROAD #101, MENLO PARK CA 94025
Elizabeth G Nabel	director	BRIGHAM AND WOMEN'S HOSPITAL, 75 FRANCIS ST, BOSTON MA 02115
Jeffrey S Brodsky	director	C/O MORGAN STANLEY 1585 BROADWAY, NEW YORK NY 10036
Thomas J Neff	director	SPENCER STUART & ASSOCIATES, 277 PARK AVE, NEW YORK NY 10172
William H. Frist	director	600 MONTGOMERY STREET, SAN FRANCISCO CA 94111